Gabapentin Capsule
Product Images NDC 50090-7672

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10, with scores decreasing more notably for Gabapentin compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

Line graph showing mean pain scores over a 7-week period for placebo and two Gabapentin dose groups (1800 mg/day and 2400 mg/day). The timeline includes a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more in the Gabapentin groups compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' displays data from two studies. It compares placebo (PBO) with Gabapentin (GBP) doses of 1800 mg, 2400 mg, and 3600 mg, showing higher proportions of responders in Gabapentin groups with statistical significance (p < 0.01, p < 0.001) indicated.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration showing the formula for calculating creatinine clearance (CLCr) incorporating factors such as age, weight, serum creatinine, and a correction factor for female patients (0.85).*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to a side chain containing an amino group (CH2NH2) and a carboxyl group (CH2CO2H). This diagram illustrates the molecular structure of gabapentin.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference on the y-axis versus daily dose in milligrams on the x-axis for Gabapentin. The chart compares three studies labeled Study a, Study b, and Study c, with data points plotted for doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg.*

FDA Label Image

Label Image (Lbl500907672)

Gabapentin 100 mg capsules label from A-S Medication Solutions. The label shows the product name, strength, lot number, storage instructions to keep at 68 to 77 degrees Fahrenheit, and a quantity of 30 capsules. The labeler address in Libertyville, IL is visible along with a barcode and references to the National Drug Code (NDC 50090-7672).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.